Jardiance (empagliflozin) is a prescription medication used to help manage blood sugar levels in adults with type 2 diabetes. It belongs to a class of drugs known as SGLT2 inhibitors (sodium-glucose co-transporter-2 inhibitors), which work by preventing the kidneys from reabsorbing glucose and instead allowing excess sugar to be eliminated through urine. While Jardiance offers many benefits, including reduced risk of cardiovascular events and improved glycemic control, it has been associated with a rare but serious side effect: necrotizing fasciitis of the perineum, also known as Fournier’s gangrene.
Looking for more information about managing type 2 diabetes? Check out our guide on diabetes management tips. And in this article you can learn about buying Jardans at a low price and about available coupons.
What Is Necrotizing Fasciitis of the Perineum?
Necrotizing fasciitis is a life-threatening bacterial infection that destroys tissue under the skin. When it occurs in the perineum—the area between the genitals and the rectum—it is called Fournier’s gangrene. This condition is characterized by rapid tissue death, severe pain, swelling, redness, and systemic symptoms such as fever and shock. Prompt diagnosis and treatment, including surgery and antibiotics, are crucial to prevent fatal outcomes. (Source)
Why Does Jardiance Increase the Risk of Necrotizing Fasciitis?
The increased risk of necrotizing fasciitis in patients taking Jardiance is likely related to the drug’s mechanism of action and its impact on the urinary tract and genital area. Here are the main factors contributing to this rare complication:
-
Increased Glucose in Urine:
Jardiance promotes glucose excretion through urine by inhibiting SGLT2 proteins in the kidneys. This creates a high-glucose environment in the urinary and genital areas, which can promote bacterial and fungal growth. The presence of excess glucose serves as an ideal nutrient source for bacteria, increasing the likelihood of infections. -
Urinary Tract and Genital Infections:
SGLT2 inhibitors, including Jardiance, are associated with a higher risk of urinary tract infections (UTIs) and genital infections such as yeast infections. While these infections are usually mild and treatable, in rare cases, they can progress to more severe conditions, including necrotizing fasciitis. -
Compromised Immune Response in Diabetic Patients:
People with type 2 diabetes often have a weakened immune system, which makes it harder for their bodies to fight off infections. This vulnerability, combined with the potential for increased bacterial growth in the genital area due to Jardiance’s effects, may increase the risk of developing serious infections like Fournier’s gangrene.
How Common Is This Side Effect?
Fournier’s gangrene is an extremely rare side effect of Jardiance and other SGLT2 inhibitors. A 2018 warning from the U.S. Food and Drug Administration (FDA) highlighted this risk based on reported cases. Over a five-year period, the FDA identified 12 cases of Fournier’s gangrene in patients taking SGLT2 inhibitors, compared to only six cases in over 30 years among patients using other diabetes medications. While the risk is low, it is critical for patients and healthcare providers to be aware of the signs and symptoms.
Symptoms to Watch For
Patients taking Jardiance should monitor for early signs of necrotizing fasciitis, including:
- Pain, redness, or swelling in the genital or perineal area
- Fever or chills
- Unusual odor or discharge from the affected area
- Rapid progression of symptoms
If any of these symptoms occur, immediate medical attention is necessary.
Reducing the Risk
To minimize the risk of necrotizing fasciitis while taking Jardiance:
- Practice good hygiene, especially in the genital and perineal areas.
- Stay hydrated to reduce the concentration of glucose in urine.
- Monitor for signs of infections and report them to your healthcare provider promptly.
- Discuss your risk factors with your doctor, particularly if you have a history of recurrent infections.
Conclusion
Although Jardiance is highly effective for managing type 2 diabetes and offers significant cardiovascular benefits, it is important to be aware of its potential risks, including the rare occurrence of necrotizing fasciitis of the perineum. By understanding the mechanisms behind this complication and recognizing early symptoms, patients and healthcare providers can work together to ensure timely intervention and reduce the risk of severe outcomes.